FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to infectious diseases. The following laboratory parameters are determined: international normalized ratio, the concentration of albumin, highly sensitive C-reactive protein. The obtained values are entered into the formula for calculating linear discriminant functions LDF1=-102.2+40.7X1+3.9X2-0.9X3, LDF2=-96.9+50.3X1+3.5X2-0.26X3, where X1 - international normalized ratio, X2 - concentration of albumin in g/l, X3 - concentration of highly sensitive C-reactive protein in mg/l. Then the values of the indicators are compared and with LDF1>LDF2 - minimal liver fibrosis is diagnosed, with LDF2>LDF1 - high-grade liver fibrosis.
EFFECT: method allows early diagnosis of the stage of fibrosis, promotes the appointment of timely therapy aimed at reducing the rate of progression of fibrosis, improving the quality of life of the child and preventing the development of cirrhosis and hepatocellular carcinoma of the liver.
1 cl, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF EARLY PROGNOSIS OF THE NATURE OF THE COURSE OF ACUTE RESPIRATORY INFECTION IN CHILDREN | 2017 |
|
RU2659384C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF LATENT AND ACTIVE FORMS OF HHV-6 INFECTION IN CHILDREN | 2023 |
|
RU2817089C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF NEONATAL HEPATITIS IN INFANTS | 2011 |
|
RU2488829C2 |
METHOD FOR DETERMINING DEGREE OF LIVER FIBROSIS | 2018 |
|
RU2675341C1 |
TECHNIQUE FOR DIAGNOSTICS OF HEPATIC FIBROSIS STAGES IN PATIENTS WITH CHRONIC VIRAL HEPATITIS C | 2015 |
|
RU2592371C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN ASSOCIATED WITH SARS-CoV-2 | 2023 |
|
RU2816437C1 |
METHOD FOR EARLY DIFFERENTIAL DIAGNOSIS OF VIRAL AND BACTERIAL COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN | 2022 |
|
RU2790239C1 |
METHOD OF ESTIMATING LIVER FIBROSIS | 2010 |
|
RU2453268C2 |
METHOD FOR PREDICTING THE COURSE OF INFLAMMATORY DISEASES OF THE NERVOUS SYSTEM IN CHILDREN | 2018 |
|
RU2689797C1 |
METHOD FOR DETERMINING HEPATIC CIRRHOSIS | 2018 |
|
RU2692988C1 |
Authors
Dates
2021-12-28—Published
2021-05-14—Filed